Invention Grant
US08969407B2 Administration of coumarin, butylated hydroxyanisole and ethoxyquine for the treatment of canities
有权
管理香豆素，丁基化羟基苯甲醚和乙氧基喹啉治疗阴茎
- Patent Title: Administration of coumarin, butylated hydroxyanisole and ethoxyquine for the treatment of canities
- Patent Title (中): 管理香豆素，丁基化羟基苯甲醚和乙氧基喹啉治疗阴茎
-
Application No.: US13689947Application Date: 2012-11-30
-
Publication No.: US08969407B2Publication Date: 2015-03-03
- Inventor: Stephane Commo
- Applicant: Stephane Commo
- Applicant Address: FR Paris
- Assignee: L'Oreal
- Current Assignee: L'Oreal
- Current Assignee Address: FR Paris
- Agency: Buchanan Ingersoll & Rooney PC
- Priority: FR0652556 20060620
- Main IPC: A61K31/45
- IPC: A61K31/45 ; A61K8/00 ; A61K8/02 ; A61Q5/00 ; A61K31/47 ; A61K31/05 ; A61K31/075 ; A61K8/49 ; A61K8/34 ; A61Q5/06
Abstract:
At least one compound selected from among coumarin and/or derivative thereof, butylated hydroxyanisole, ethoxyquine and mixtures thereof, and admixtures thereof with other active agents selected from among active agents for combating desquamative conditions of the scalp, plant extracts having propigmenting activity and active agents that slow hair loss and/or promote hair regrowth, are useful for preventing and/or limiting and/or stopping the development of canities.
Public/Granted literature
- US20130149360A1 ADMINISTRATION OF COUMARIN, BUTYLATED HYDROXYANISOLE AND ETHOXYQUINE FOR THE TREATMENT OF CANITIES Public/Granted day:2013-06-13
Information query
IPC分类:
